AT265535T
Pharmaceutical composition for treating papillomavirus tumours and infection
Abstract
The present invention relates to a pharmaceutical composition for treating or preventing an infection or tumor papillomavirus comprising as therapeutic agents, a polypeptide OIGINARIO OF A REGION EARLY AND A polypeptide OIGINARIO A late region of a papillomavirus, any associated A polypeptide having immunostimulant, or a polypeptide OIGINARIO OF AN EARLY REGION OR DELAYED of a papillomavirus and a polypeptide having ACTIVITY IMMUNOSTIMULANT Or, alternatively, a recombinant vector into which are inserted DNA fragments CODING FOR COMBINATIONS ABOVE polypeptides.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
40 members in 13 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 9609584 | France | A |
Members40
| Document | Office | Kind | |
|---|---|---|---|
| CA2234263A1 | Canada | A1 | |
| WO9804705A1 | World Intellectual Property Organization (WIPO) | A1 | |
| FR2751879A1 | France | A1 | |
| AU3855297A | Australia | A | |
| EP0862634A1 | European Patent Office (EPO) | A1 | |
| FR2751879B1 | France | B1 | |
| JP2000500662A | Japan | A | |
| AU736720B2 | Australia | B2 | |
| EP0862634B1 | European Patent Office (EPO) | B1 | |
| AT205881T | Austria | T | |
| ATE205881T1 | Austria | T1 | |
| DE69706825D1 | Germany | D1 | |
| EP1149910A1 | European Patent Office (EPO) | A1 | |
| DK0862634T3 | Denmark | T3 | |
| ES2163795T3 | Spain | T3 | |
| PT862634E | Portugal | E | |
| DE69706825T2 | Germany | T2 | |
| HK1043809A1 | Hong Kong, China | A1 | |
| EP1149910B1 | European Patent Office (EPO) | B1 | |
| AT265535TThis record | Austria | T | |
| ATE265535T1 | Austria | T1 | |
| DE69728914D1 | Germany | D1 | |
| DK1149910T3 | Denmark | T3 | |
| PT1149910E | Portugal | E | |
| ES2215805T3 | Spain | T3 | |
| HK1043809B | Hong Kong, China | B | |
| DE69728914T2 | Germany | T2 | |
| EP0862634B2 | European Patent Office (EPO) | B2 | |
| DK0862634T4 | Denmark | T4 | |
| ES2163795T5 | Spain | T5 | |
| DE69706825T3 | Germany | T3 | |
| US7118754B1 | United States of America | B1 | |
| US2007065459A1 | United States of America | A1 | |
| JP2007254474A | Japan | A | |
| JP4070815B2 | Japan | B2 | |
| JP4198735B2 | Japan | B2 | |
| US7488482B2 | United States of America | B2 | |
| US2009104156A1 | United States of America | A1 | |
| CA2234263C | Canada | C | |
| US7670607B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1109013
Titles2
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNG GEGEN DURCH PAPILLOMAVIREN VERURSACHTE TUMOREN UND INFEKTIONEN
- English
- PHARMACEUTICAL COMPOSITION AGAINST PAPILLOMA VIRUSES AND INFECTIONS
Classification
- CPC, 8
- C07K14/005
- A61K39/00
- A61P31/00
- C12N2710/20022
- A61P31/12
- C12N2710/24143
- A61P31/20
- A61P35/00
- IPC, 17
- A61K31 00
- A61K31 70
- A61K31 7088
- A61K35 76
- A61K38 00
- A61K39 00
- A61K39 385
- A61K48 00
- A61P31 00
- A61P31 12
- A61P31 20
- A61P35 00
- C07K14 025
- C12N15 00
- C12N15 09
- C12N15 37
- C12R1 92